235. 副甲状腺機能低下症 Hypoparathyroidism Clinical trials / Disease details

臨床試験数 : 88 / 薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04465227 (ClinicalTrials.gov)	July 15, 2020	9/7/2020	Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305in Autosomal Do ...	A Phase IIb, Open-label Dose-ranging Study Evaluating the Safety, Tolerability, Pharmacodynamics and ...	Hypoparathyroidism	Drug: CLTX-305	National Institute of Dental and Craniofacial Research (NIDCR)	NULL	Not yet recruiting	16 Years	N/A	All	20	Phase 2	United States

First Previous1Next Last